Prosight Management, LP Quant / Systematic

CIK: 0001617201 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 14, 2020

Total Value ($000): $227,749 (100.0% shares, 0.0% debt)

Holdings (38)

ZBH ZIMMER BIOMET HLDGS INC 8.5%
Value ($000) $19,458 Shares 130,000 Est. Cost $110.07 Unrealized +19.3%
QURE UNIQURE NV 7.5%
Value ($000) $17,019 Shares 237,500 Est. Cost $59.89 Unrealized -8.3%
ARENA PHARMACEUTICALS INC 6.5%
Value ($000) $14,904 Shares 328,129 Est. Cost $43.81 Unrealized
KURA KURA ONCOLOGY INC 6.3%
Value ($000) $14,245 Shares 1,036,000 Est. Cost $16.30 Unrealized -9.1%
UTHR UNITED THERAPEUTICS CORP DEL 6.2%
Value ($000) $14,198 Shares 161,195 Est. Cost $82.53 Unrealized +6.6%
REATA PHARMACEUTICALS INC 5.6%
Value ($000) $12,859 Shares 62,900 Est. Cost $46.26 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 4.7%
Value ($000) $10,756 Shares 388,600 Est. Cost $12.80 Unrealized +77.7%
ACIU AC IMMUNE SA 4.6%
Value ($000) $10,589 Shares 1,242,843 Est. Cost $5.81 Unrealized +14.7%
MGTX MEIRAGTX HOLDINGS PLC 4.6%
Value ($000) $10,367 Shares 517,844 Est. Cost $21.14 Unrealized -19.0%
ARQULE INC 3.9%
Value ($000) $8,989 Shares 450,326 Est. Cost $10.31 Unrealized
CNC CENTENE CORP DEL 3.9%
Value ($000) $8,978 Shares 142,800 Est. Cost $55.81 Unrealized -2.8%
ALDX ALDEYRA THERAPEUTICS INC 3.6%
Value ($000) $8,298 Shares 1,428,277 Est. Cost $7.50 Unrealized -23.0%
BMRN BIOMARIN PHARMACEUTICAL INC 3.4%
Value ($000) $7,841 Shares 92,737 Est. Cost $85.05 Unrealized -11.2%
URGN UROGEN PHARMA LTD 3.2%
Value ($000) $7,264 Shares 217,686 Est. Cost $38.49 Unrealized -29.1%
ARENA PHARMACEUTICALS INC 2.8%
Value ($000) $6,468 Shares 142,400 Est. Cost Unrealized
ALBIREO PHARMA INC 2.8%
Value ($000) $6,283 Shares 247,178 Est. Cost $29.61 Unrealized
NVST ENVISTA HLDGS CORP 2.1%
Value ($000) $4,891 Shares 165,000 Est. Cost $28.45 Unrealized 0.0%
PSNL PERSONALIS INC 1.9%
Value ($000) $4,433 Shares 406,673 Est. Cost $14.12 Unrealized -26.3%
ANAB ANAPTYSBIO INC 1.7%
Value ($000) $3,816 Shares 234,823 Est. Cost $23.65 Unrealized 0.0%
IMVT IMMUNOVANT INC 1.6%
Value ($000) $3,566 Shares 224,702 Est. Cost $11.17 Unrealized 0.0%
ORGO ORGANOGENESIS HLDGS INC 1.3%
Value ($000) $2,972 Shares 617,836 Est. Cost $6.34 Unrealized 0.0%
EOLS EVOLUS INC 1.3%
Value ($000) $2,884 Shares 236,939 Est. Cost $14.10 Unrealized 0.0%
CATALYST BIOSCIENCES INC 1.2%
Value ($000) $2,669 Shares 391,894 Est. Cost $9.00 Unrealized
STRONGBRIDGE BIOPHARMA PLC 1.2%
Value ($000) $2,630 Shares 1,258,224 Est. Cost $3.69 Unrealized
R1 RCM INC 1.1%
Value ($000) $2,596 Shares 200,000 Est. Cost $8.93 Unrealized
EVH EVOLENT HEALTH INC 1.1%
Value ($000) $2,528 Shares 279,390 Est. Cost $8.12 Unrealized 0.0%
CI CIGNA CORP NEW 1.0%
Value ($000) $2,309 Shares 11,293 Est. Cost $179.32 Unrealized -6.5%
MOLECULAR TEMPLATES INC 1.0%
Value ($000) $2,250 Shares 160,883 Est. Cost $5.90 Unrealized
CUE CUE BIOPHARMA INC 1.0%
Value ($000) $2,185 Shares 137,628 Est. Cost $10.47 Unrealized 0.0%
ALLAKOS INC 0.9%
Value ($000) $1,974 Shares 20,700 Est. Cost Unrealized
PARATEK PHARMACEUTICALS INC 0.8%
Value ($000) $1,814 Shares 450,000 Est. Cost $4.03 Unrealized
TNET TRINET GROUP INC 0.7%
Value ($000) $1,591 Shares 28,104 Est. Cost $54.24 Unrealized 0.0%
KEZAR LIFE SCIENCES INC 0.6%
Value ($000) $1,283 Shares 320,000 Est. Cost $4.01 Unrealized
TELIGENT INC NEW 0.3%
Value ($000) $632 Shares 1,484,527 Est. Cost $3.21 Unrealized
AXSOME THERAPEUTICS INC 0.3%
Value ($000) $620 Shares 6,000 Est. Cost Unrealized
MIST MILESTONE PHARMACEUTICALS IN 0.3%
Value ($000) $616 Shares 38,481 Est. Cost $17.77 Unrealized 0.0%
BMY BRISTOL MYERS SQUIBB CO 0.2%
Value ($000) $520 Shares 8,100 Est. Cost $37.62 Unrealized +20.1%
APOLLO ENDOSURGERY INC 0.2%
Value ($000) $454 Shares 159,336 Est. Cost $2.85 Unrealized